drugset / Trial / NCT02717780

Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome

NCT02717780

Phase 4 Completed 60 enrolled Centre Hospitalier Universitaire Vaudois
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigators aim to assess the respiratory effect of short half-life agents in balanced anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable polygraphies: the night before the surgery ; the first night following the surgery ; the third night following the surgery.

Timeline

Start
2016-02
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Desflurane Other / unclassified
Comparator Fentanyl Other / unclassified
Subject Remifentanil Small molecule
Comparator Sevoflurane Other / unclassified